高T2型支气管哮喘生物标志物的研究进展  

Research Progress of Biomarkers for High T2-Type Bronchial Asthma

作　　者：王敏珊 吴峰 WANG Minshan;WU Feng(Guangdong Medical University,Zhanjiang 524000,China;Department of Respiratory,Third People's Hospital of Huizhou,Huizhou 516000,China)

机构地区：[1]广东医科大学,广东省湛江市524000 [2]广东省惠州市第三人民医院呼吸内科,516000

出　　处：《实用心脑肺血管病杂志》2025年第3期132-135,140,共5页Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease

基　　金：广东省卫生健康适宜技术推广项目(793)。

摘　　要：支气管哮喘是一种复杂的异质性疾病,具有许多临床和生物学表现,涉及多种潜在的病理生理机制。近几十年来,支气管哮喘的生物标志物已成功用于疾病的诊治与监测。在临床上,有各种有创和无创的血液和气道检测方法来评估高T2型支气管哮喘。本文综述了高T2型支气管哮喘的发病机制及其生物标志物,以期为支气管哮喘的临床诊疗提供参考。Bronchial asthma is a complex and heterogeneous disease with many clinical and biological manifestations,which involves a variety of underlying pathophysiological mechanisms.In recent decades,biomarkers of bronchial asthma have been successfully used in the diagnosis,treatment and monitoring of the disease.In clinical practice,there are various invasive and non-invasive blood and airway testing methods to assess high T2-type bronchial asthma.This article reviews the pathogenesis and biomarkers of high T2-type bronchial asthma,in order to provide reference for the diagnosis and treatment of bronchial asthma in clinical practice.

关 键 词：支气管哮喘 生物标志物 综述 

分 类 号：R562.25[医药卫生—呼吸系统]